What distinguishes methamphetamine withdrawal from most other substance withdrawals is not its physical danger — meth withdrawal does not carry the seizure risk of alcohol or benzodiazepine withdrawal, and it does not require a medical taper. What distinguishes it is its length and its psychological weight. The acute crash is severe. The weeks that follow are a different kind of hard. And the full arc — from the crash through post-acute recovery — extends for months.
Understanding the timeline changes how people navigate it. When you know that the acute crash typically bottoms out around day 3 before beginning a gradual improvement, and that the cognitive fog of weeks 2–4 is a predictable phase rather than evidence that something went permanently wrong, the experience becomes more navigable. Not easier, but navigable.
This article maps the meth withdrawal timeline based on clinical research, primarily McGregor and colleagues' 2005 study of methamphetamine withdrawal phenomenology, which remains one of the most detailed longitudinal descriptions of the experience.
TL;DR: Meth withdrawal runs in three phases: the crash (days 1–3), acute withdrawal (days 4–21), and post-acute withdrawal syndrome or PAWS (weeks 3 through months 6–24). The crash is the most acutely miserable phase — extreme fatigue, hypersomnia, and dysphoria. Acute withdrawal brings insomnia, intense cravings, anhedonia, and mood instability. PAWS is characterized by intermittent depression, cognitive difficulties, sleep disruption, and periodic craving surges that can persist for up to two years in heavy long-term users. The worst of the acute phase typically passes within two to three weeks. If suicidal thoughts arise during the crash or early acute phase, contact 988 (call or text) immediately — this is a recognized risk window.
Phase 1: The crash (days 1–3)
The crash begins within hours of the last dose. For someone who has been awake for days during a heavy run, it may begin the moment the drug wears off and sleep becomes unavoidable.
What characterizes the crash:
- Hypersomnia. Sleeping 12–18 hours per day is common. The body is catching up on sleep deprivation that may span days. This is a physical demand, not laziness.
- Extreme fatigue. Even when awake, energy is near zero. Simple tasks feel effortful.
- Severe dysphoria. A profound mood floor — not sadness exactly, but a complete absence of positive emotional tone. This is dopamine depletion: the reward system that meth supercharged is now running on a nearly empty reserve.
- Increased appetite. Meth suppresses appetite severely. The crash reverses this, often dramatically. Eating during the crash is a recovery-relevant behavior, not a loss of control.
- Minimal cravings. Counterintuitively, the crash phase often involves lower acute cravings than the following week. The body is too depleted to generate strong wanting states.
The crash is physiologically unpleasant but typically not medically dangerous. It does not require clinical management in most cases. The main safety concern during the crash is suicidal ideation — the combination of extreme dysphoria and depleted dopaminergic tone can lower the threshold for passive suicidal thoughts. If this occurs, contact 988 (call or text).
Phase 2: Acute withdrawal (days 4–21)
As the crash resolves — usually by day 3 or 4 — a different and in some ways more challenging phase begins. The hypersomnia resolves, but normal sleep does not return. Energy partially rebounds, but with it come cravings, irritability, and the full weight of anhedonia.
What characterizes acute withdrawal:
Days 4–7: Fatigue begins to lift but remains heavy. Insomnia replaces hypersomnia — the sleep architecture that meth disrupted does not normalize immediately. Cravings emerge. Mood is unstable: irritability, anxiety, and emotional flatness alternate unpredictably. Concentration is poor.
Days 7–14: The anhedonia becomes more pronounced. Things that should feel rewarding — food, social connection, activity — register as neutral or mildly unpleasant. This is not depression per se (though it overlaps with depressive symptomatology); it is the specific reward deficit that follows dopamine depletion. Cravings may intensify in this window. Sleep remains disrupted: difficulty initiating sleep, fragmented sleep, vivid dreams or nightmares.
Days 14–21: Gradual improvement begins for most people. The mood floor lifts slightly. Brief windows of normalcy appear — a few hours when things feel tolerable, even occasionally okay. These windows are real neurological improvement, not coincidence. The anhedonia does not resolve, but it becomes intermittent rather than constant.
McGregor and colleagues (2005) documented that the peak of acute withdrawal symptoms — measured across depression, anxiety, fatigue, and craving subscales — typically occurred during the first two weeks, with a gradual decline across weeks 2–4. This is consistent with what people in recovery describe.
The risk window for return to use. Weeks 2–4 represent the period of highest risk for returning to meth use. The crash has passed (so the extreme fatigue that kept use impossible is gone), but neurological recovery is far from complete. Cravings are often at their peak. Environmental triggers are still powerful. Understanding this window as a high-risk period is useful: it is not the time to resume normal life as if recovery is complete.
Phase 3: Post-acute withdrawal syndrome (weeks 3 through months 6–24)
Post-acute withdrawal syndrome, or PAWS, is the extended neurological recovery phase that follows the acute withdrawal window. It is not a continuous state of intense suffering — it is characterized by intermittent waves of symptoms that gradually decrease in frequency and intensity over months.
PAWS from methamphetamine is longer and in some respects more pronounced than PAWS from cocaine, reflecting meth's more extensive effects on the dopamine transporter and the monoamine system broadly.
Core PAWS symptoms:
- Anhedonia. The most persistent feature of meth PAWS. The capacity for pleasure — from food, social connection, sex, accomplishment — is reduced. It improves gradually and unevenly. For a detailed discussion, see Meth Anhedonia in Early Recovery.
- Cognitive difficulties. Working memory, concentration, and executive function are impaired. This is measurable neurologically and reflects the ongoing recovery of prefrontal cortex function. It typically improves meaningfully by months 3–6, with further improvement through month 12.
- Sleep disruption. Insomnia, fragmented sleep, abnormal sleep architecture, and vivid dreams can persist for months. The REM suppression that meth produces during active use is followed by a REM rebound during early abstinence (intense dreaming), which then gradually normalizes.
- Mood instability. Periods of depression, anxiety, and irritability that are disproportionate to circumstances. These are PAWS phenomena — they reflect neurological recovery, not a new psychiatric disorder, though clinical assessment is appropriate if they are severe or persistent.
- Craving surges. Periodic intense cravings triggered by environmental cues, stress, or apparently random neurological events. These often arrive without warning and feel disproportionately strong, particularly in the first several months. Understanding them as conditioned neurological responses rather than evidence of weakness changes how they can be managed.
Timeline: The majority of PAWS symptoms improve significantly by months 3–6 for most users. For heavy long-term users, meaningful symptoms can persist up to 24 months. The improvement is not linear — many people describe a "one step back" pattern where several good weeks are followed by a bad week, then a return to the improved baseline.
What the timeline means in practice
The meth withdrawal timeline is not a linear march from sick to well. It is a gradual reorganization of the brain's reward and stress systems — two systems that methamphetamine destabilized significantly and that take longer to recover than people are typically told.
A few practical implications:
The two-week mark is not recovery. Feeling better at week two compared to the crash is real neurological improvement. It is not the end of the withdrawal arc. Many people return to the conditions of active use at this point and encounter triggers they are not yet equipped to manage neurologically.
Cognitive impairment is temporary. The difficulty thinking clearly, making decisions, and maintaining focus in weeks 2–8 is a neurological effect of meth on the prefrontal cortex. It improves. Treating this period as one requiring reduced cognitive demands — simpler routines, structured support, reduced decision-making complexity — is appropriate and evidence-based.
Sleep disruption is the longest-lasting acute symptom. Expecting sleep to normalize in the first weeks is unrealistic. Planning for ongoing sleep difficulty in months 1–3 and building sleep hygiene practices into early recovery structures the expectation correctly. For more on this, see Meth and Sleep Recovery.
The PAWS window is the full game. The acute crash and withdrawal are the opening phase of a recovery arc that runs for months. The people who navigate meth recovery most successfully are not the ones who outlast the crash — they are the ones who build the structures (support, routine, behavioral tools) that carry them through the PAWS phase.
For what happens in the brain during this process, see Meth Brain Recovery.
Coach Aria offers private, evidence-based recovery coaching for people in methamphetamine and stimulant recovery. Start here — your information is never shared.